TEMPO 1% Dust Insecticide Ready To Use

A Business Group of BAYER CROPSCIENCE, LP

Revision date : 2004-02-10

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

68359-37-5

Name of the chemical

Cyfluthrin (ISO); α-Cyan-4-fluor-3-phenoxybenzyl-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat (2022/692)

Concentration

N/A

EC/CAS

14808-60-7

Name of the chemical

Silica, crystalline

Concentration

N/A

General Information

Revision date

2004-02-10

Product name

TEMPO 1% Dust Insecticide Ready To Use

Product Synonyms

Cyfluthrin

Chemical name

Cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2 -dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate

1.2.1 Relevant identified uses

Commercial Insecticide -------------------------------------------------------------------------------

Icons in SDS

Company Information

company name

A Business Group of BAYER CROPSCIENCE, LP

Section 2

SECTION 2: Hazards identification

EMERGENCY OVERVIEW * CAUTION! Color White to off-white; Form Solid; Powder; * Odor: Musty talc; Harmful if inhaled; Harmful if absorbed * * through skin; Causes eye irritation; Harmful if swallowed. * *****************************************************************

Principle Routes of Exposure

Inhalation; Skin Contact; Eye Contact HUMAN EFFECTS AND SYMPTOMS OF OVEREXPOSURE: ACUTE EFFECTS OF EXPOSURE.....: Sufficient exposure to cyfluthin, the active ingredient in this product, may cause eye and skin irritation characterized by redness or itching. In addition, sufficient exposure to cyfluthrin may produce paraesthesia (a tingling or burning sensation on the surface of the skin). This is a frequently reported symptom associated with sufficient dermal exposure to alpha-cyano (or Type II) synthetic pyrethroids and normally subsides without treatment within 24 hours. The onset of these symptoms usually occurs 2-12 hours after exposure. Mucous membrane irritation involving the nose, throat and upper respiratory tract may occur from inhalation of aerosols containing cyfluthrin.

Potential chronic health

OF EXPOSURE... Based on animal studies, no adverse effects or symptoms would be expected from chronic exposure to the active ingredient in this product during normal use. This product may contain up to approximately 5% total crystalline silica. However, the amount of respirable crystalline silica is expected to be significantly lower based on data provided by the raw material manufacturer. Excessive long-term exposure to respirable crystalline silica may cause silicosis, a form of progressive pulmonary fibrosis. Severe and permanent lung damage may result. CARCINOGENICITY...............: This product is not listed as a carcinogen by NTP or IARC, or regulated as a carcinogen by OSHA. However, it may contain crystalline silica (quartz), a substance which is classified by NTP as a Group 2 carcinogen and by IARC as a Group I carcinogen. Crystalline silica is a naturally-occurring mineral component of many sands and clays. Although controversial, the carcinogenic potential of crystalline silica must be considered if it is inhaled under excessive exposure conditions. However, the respirable portion of the silica which may be contained in this product is small, such that excessive inhalation exposure during normal conditions of use is unlikely. NTP.........................: Crystalline silica is classified as an NTP Anticipated Human Carcinogen - "Substances or groups of substances that may reasonably be anticipated to be carcinogens." IARC........................: IARC has classified crystalline silica as a (Continued) --------------------------------------- Group 1 carcinogen. "There is sufficient evidence in humans for the carcinogenicity of inhaled crystalline silica (quartz) from occupational sources." OSHA........................: Not regulated MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE......: No specific medical conditions are known which may be aggravated by exposure to the active ingredient in this product. As with all materials which can cause upper respiratory tract irritation, persons with a history of asthma, emphysema, or hyperreactive airways disease may be more susceptible to a response at low concentration. In addition, pulmonary and respiratory diseases may be aggravated by exposure to respirable crystalline silica. -------------------------------------------------------------------------------

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.